VRNA vs. IRTC
VRNA (Verona Pharma plc) and IRTC (iRhythm Technologies, Inc.) are both stocks. Both are in the Healthcare sector — VRNA in Biotechnology, IRTC in Medical Devices. At a 0.12 correlation, their price movements are largely independent.
Performance
VRNA vs. IRTC - Performance Comparison
Loading charts...
Returns By Period
VRNA
- 1D
- —
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
IRTC
- 1D
- 0.87%
- 1M
- -0.88%
- YTD
- -35.95%
- 6M
- -32.68%
- 1Y
- -21.88%
- 3Y*
- 3.87%
- 5Y*
- 12.21%
- 10Y*
- —
VRNA vs. IRTC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
VRNA Verona Pharma plc | 0.00% | 130.21% | 133.60% | -23.92% | 288.84% | -4.00% | 21.74% | -40.41% | -18.71% | -12.07% |
IRTC iRhythm Technologies, Inc. | -35.95% | 96.78% | -15.76% | 14.27% | -20.41% | -50.39% | 248.38% | -2.00% | 23.96% | 61.95% |
Correlation
The correlation between VRNA and IRTC is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.05 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Apr 27, 2017 | 0.12 |
The correlation between VRNA and IRTC shifts across timeframes, from 0.05 (1 year) to 0.16 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
VRNA:
$9.72B
IRTC:
$3.69B
VRNA:
-$0.69
IRTC:
-$0.85
VRNA:
57.97
IRTC:
4.69
VRNA:
34.92
IRTC:
22.92
VRNA:
$167.65M
IRTC:
$787.85M
VRNA:
$159.52M
IRTC:
$559.39M
VRNA:
-$40.86M
IRTC:
-$3.10M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VRNA vs. IRTC — Risk / Return Rank
VRNA
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
IRTC
VRNA vs. IRTC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Verona Pharma plc (VRNA) and iRhythm Technologies, Inc. (IRTC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VRNA | IRTC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 0.94 | — |
| Calmar ratioReturn relative to maximum drawdown | — | -0.49 | — |
| Martin ratioReturn relative to average drawdown | — | -0.99 | — |
Loading charts...
Drawdowns
VRNA vs. IRTC - Drawdown Comparison
Loading charts...
Drawdown Indicators
| VRNA | IRTC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | — | -84.39% | — |
Max Drawdown (1Y)Largest decline over 1 year | — | -44.75% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -53.83% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -66.03% | — |
Current DrawdownCurrent decline from peak | — | -57.67% | — |
Average DrawdownAverage peak-to-trough decline | — | -37.10% | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 22.10% | — |
Volatility
VRNA vs. IRTC - Volatility Comparison
Loading charts...
Volatility by Period
| VRNA | IRTC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 11.53% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 32.11% | — |
Volatility (1Y)Calculated over the trailing 1-year period | — | 42.84% | — |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | — | 63.42% | — |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | — | 61.72% | — |
Dividends
VRNA vs. IRTC - Dividend Comparison
Neither VRNA nor IRTC has paid dividends to shareholders.
Financials
VRNA vs. IRTC - Financials Comparison
This section allows you to compare key financial metrics between Verona Pharma plc and iRhythm Technologies, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
VRNA vs. IRTC - Profitability Comparison
VRNA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Verona Pharma plc reported a gross profit of 71.68M and revenue of 75.14M. Therefore, the gross margin over that period was 95.4%.
IRTC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, iRhythm Technologies, Inc. reported a gross profit of 141.35M and revenue of 199.39M. Therefore, the gross margin over that period was 70.9%.
VRNA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Verona Pharma plc reported an operating income of 9.69M and revenue of 75.14M, resulting in an operating margin of 12.9%.
IRTC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, iRhythm Technologies, Inc. reported an operating income of -16.19M and revenue of 199.39M, resulting in an operating margin of -8.1%.
VRNA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Verona Pharma plc reported a net income of 8.69M and revenue of 75.14M, resulting in a net margin of 11.6%.
IRTC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, iRhythm Technologies, Inc. reported a net income of -13.93M and revenue of 199.39M, resulting in a net margin of -7.0%.
Frequently Asked Questions
VRNA and IRTC have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for VRNA and IRTC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer